Prof Kylie Gorringe
Honorary Conjoint Professorial Fellow
The Sir Peter MacCallum Department of Oncology
164 Scholarly works
17 Projects
HIGHLIGHTS
2026
Journal article
Molecular pathology of phyllodes tumours of the breast—much more than MED12
DOI: 10.1111/his.700982026
Journal article
Androgen steroidogenesis and functional effect in mucinous ovarian cancer cells, organoids and patient tumours
DOI: 10.1530/endoabs.117.p912026
Journal article
A 5-marker immunohistochemical panel of CK17, MEP1A, PAX8, SMAD4, and CDX2 to distinguish ovarian mucinous carcinoma from metastatic pancreatic ductal adenocarcinoma
DOI: 10.1111/his.700022025
Research grants (ARC, NHMRC, MRFF)
Lineage Tracing to Identify Ovarian Cancer Cells of Origin
2022
Research grants (other domestic)
Harnessing Innate Immune Cells for Breast Cancer Prevention
2021
Research Grant
Discovering the Cell of Origin for Rare Ovarian Cancers
2012
Journal article
CONTRA: Copy number analysis for targeted resequencing
DOI: 10.1093/bioinformatics/bts146
RECENT SCHOLARLY WORKS
2026
Journal article
Phylogenetic analysis of paired breast carcinomas identifies genetic events associated with clonal recurrence and invasive progression
DOI: 10.1002/path.64612025
Other
Table 2 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
DOI: 10.1158/1078-0432.307063352025
Other
Supplementary Tables S1-S11 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
DOI: 10.1158/1078-0432.307063472025
Other
Figure 2 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
DOI: 10.1158/1078-0432.307063682025
Other
Supplementary Figures S1-S13 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
DOI: 10.1158/1078-0432.307063562025
Other
Table 1 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
DOI: 10.1158/1078-0432.307063442025
Other
Supplementary Methods 1 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
DOI: 10.1158/1078-0432.30706353
RECENT PROJECTS
2025
Research grants (other domestic)
New Treatments for Mucinous Ovarian Carcinoma